PhD in Biochemistry (University of Barcelona) and Executive MBA (La Salle – Ramon Llull University).
Specialist in gene regulation and epigenetics in neurodegenerative and neurological diseases such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease and Schizophrenia. Author of 36 scientific articles published in international journals related to neurosciences, h index equal to 22, and inventor of 7 patents. Miguel Servet researcher (Institute of Health Carlos III - ISCIII) in 2008, she holds a permanent position in IDIBELL as principal investigator. She has leaded several national and private competitive projects in the last 14 years (Institute of Neuropathology – Bellvitge Hospital – IDIBELL). She has directed two doctoral thesis and five experimental masters. Member of the Scientific Review Board at the Alzheimer's Drug Discovery Foundation.
Ramón ReñéMedical Advisory Board
Medical Advisory Board
Head of Functional Dementia Unit in Bellvitge University Hospital. He has large experience in the treatment of patients with Mild Cognitive Impairment, Vascular Dementia, Frontotemporal Degeneration and Dementia with Lewy Bodies. He has leaded more than ten clinical trials in the last five years in collaboration with pharmaceutical companies (GSK, Sanofi, Noscira, Servier, Grifols, Lundbeck, Astra Zeneca, Eli Lilly, Biogen and Roche). Moreover, he has also been focused on caregivers, maintaining a tight vinculation with Alzheimer’s familiar Associations.
Jordi GascónMedical Advisory Board
Medical Advisory Board
Neurologist specialist in Dementia and Neurometabolic diseases in the Functional Dementia Unit of Bellvitge University Hospital. Associate professor in Morphological Sciences in Autonomous University of Barcelona. Expert in the management and treatment of Mild cognitive impairment and Dementias: Alzheimer’s disease, Dementia with Lewy Bodies, Frontotemporal Dementia and Amyotrophic lateral Sclerosis with cognitive or behavioural impairment. He is a reference neurologist for the treatment of Niemann-Pick C in the adult. Large experience in clinical trials with pharmaceutical companies in the last ten years and as a consultant at his hospital.
Julián PeñaFinancial Manager
Over 15 years of experience in financial management of biotech, biomedicine and nanotechnology projects (Celltec-UB, Advancell, Fundación Hospital Clinic, Endor Nanotechnologies, Bionure). Holds a Diploma in Business Sciences and is a professor in the Degree in Biotechnology at the University of Barcelona.
Lidia CasasPatent Attorney
Lídia is Qualified European Patent Attorney (EQE-2014) and has a degree in Biochemistry. She is a professional with 19 years experience in Intellectual Property, especially in the fields of biotechnology, biomedicine and medtech. She created her own project of patent consultancy particularly for start-up companies, Patent Riders. Lídia works for ADmit Therapeutics as external IP Manager, managing all the aspects of IP of the company.
Josep Lluís FalcóRegulatory Advisor
Josep Lluís Falcó
Doctor in Chemistry (Institut Químic de Sarrià) and MBA (Universitat de Barcelona).
Josep Lluís has 21 years of experience in the biomedical sector. He has worked for big pharma companies (Sanofi), mid-size pharmas (Ferrer Grupo), small biotechs (Hospital spin-off), Tech Transfer Offices (Fundació Bosch i Gimpera) and Consulting firms (Antares Consulting and Asphalion). He has also been associate professor at IQS. His experience is based in Healthcare Strategy, Technology Transfer, Fundraising of start-up companies, Business Development, Marketing, Market Access, Reimbursement and Regulatory Affairs. He has global knowledge of drug/device development, having worked in Discovery, Preclinical and Clinical phases, Marketing and Post-Marketing. He takes part of programs such as Caixa Impulse and EIT Health programs, participating as reviewer, mentor and professor. The entrepreneurial spirit runs through his veins. He has founded GENESIS Biomed to help other entrepreneurs and research centers in their current projects.
Antonio SoaresBusiness Strategy and Development Advisor
Business Strategy and Development Advisor
Antonio is an entrepreneur with a scientific background in life&clinical sciences that has worked as an advisor to leading health & diagnostic corporations and SME's, where he has developed and implemented market entry and growth strategies in global markets (focus on US and Central and Eastern Europe). Antonio has worked in Europe and the US with senior business unit executives to help strategic development processes as well as defined and analyzed critical new business development opportunities for companies. Extensive experience with business development advisory including management of intelectual property. Acquainted to work with multicultural teams and a strong network in health diagnostics, medical devices and agro-food business sectors. Measurable track record in realising growth for both multinationals as well as specialised SME’s. Excellent commercial skills and good communication and social abilities. Throughout his career he has been involved in executing business intelligence, corporate strategy, developing market entry and growth strategies, transaction & implementation (incorporation, JV’s, M&A, strategic partnerships), public-private partnerships and financing.